For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...

Adrenomedullin disrupts insulin signaling in blood vessels, leading to systemic insulin resistance in obesity-associated type 2 diabetes.

The platform enables direct, unbiased genome-wide identification and quantification of the exact position of double strand DNA breaks in edited cells.

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Uniphar is expanding its footprint with new facilities in the United States and elsewhere to better support pharma and medtech manufacturers.

A new approach that used CRISPR to engineer adipocytes and implant them in mice models of cancer reduced cancer progression.

The modular sterile filling system reportedly can deliver 500 to 50,000 units per batch specifically tailored for process development.

AI-powered research on one of the largest eye studies to date has created the most detailed maps of the retina ever produced.

Researcher suggest findings could help understand what happens in the brain when fear response regulation is impaired.

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

CEO Serge Saxonov, PhD, says provider of single cell, spatial, and in situ instruments expects to see benefits from sales ...

A few companies are in clinicals with novel approaches to heal an initial brain injury or minimize secondary damage. Slow progress may be more related to investors’ misperceptions of the topic than ...